Lexeo Therapeutics, Inc. (LXEO) stock
LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.95+0.10 (+3.33%)
Close on Nov 18, 2026Market cap $242.04MP/E –Yield –
Lexeo Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Lexeo Therapeutics's revenue for the twelve months ending Dec 31, 2022 was $654.00K. For fiscal 2022 it was $654.00K.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $654.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $531.00K | – |
See a number that looks wrong?